annual cash & cash equivalents:
$95.88M-$54.40M(-36.20%)Summary
- As of today (May 20, 2025), DVAX annual cash & cash equivalents is $95.88 million, with the most recent change of -$54.40 million (-36.20%) on December 31, 2024.
- During the last 3 years, DVAX annual cash & cash equivalents has fallen by -$340.31 million (-78.02%).
- DVAX annual cash & cash equivalents is now -78.02% below its all-time high of $436.19 million, reached on December 31, 2021.
Performance
DVAX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$51.72M-$44.16M(-46.06%)Summary
- As of today (May 20, 2025), DVAX quarterly cash & cash equivalents is $51.72 million, with the most recent change of -$44.16 million (-46.06%) on March 1, 2025.
- Over the past year, DVAX quarterly cash & cash equivalents has dropped by -$80.31 million (-60.83%).
- DVAX quarterly cash & cash equivalents is now -88.14% below its all-time high of $436.19 million, reached on December 31, 2021.
Performance
DVAX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DVAX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.2% | -60.8% |
| 3 y3 years | -78.0% | -71.2% |
| 5 y5 years | +140.4% | +36.5% |
DVAX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -78.0% | at low | -79.2% | at low |
| 5 y | 5-year | -78.0% | +198.9% | -88.1% | +61.3% |
| alltime | all time | -78.0% | +1754.2% | -88.1% | +911.0% |
DVAX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $51.72M(-46.1%) |
| Dec 2024 | $95.88M(-36.2%) | $95.88M(-19.7%) |
| Sep 2024 | - | $119.33M(+6.1%) |
| Jun 2024 | - | $112.50M(-14.8%) |
| Mar 2024 | - | $132.03M(-12.1%) |
| Dec 2023 | $150.28M(-25.6%) | $150.28M(-2.7%) |
| Sep 2023 | - | $154.51M(-31.9%) |
| Jun 2023 | - | $226.82M(+30.1%) |
| Mar 2023 | - | $174.35M(-13.7%) |
| Dec 2022 | $202.00M(-53.7%) | $202.00M(+1.7%) |
| Sep 2022 | - | $198.58M(-20.3%) |
| Jun 2022 | - | $249.09M(+38.8%) |
| Mar 2022 | - | $179.42M(-58.9%) |
| Dec 2021 | $436.19M(+1260.0%) | $436.19M(+77.1%) |
| Sep 2021 | - | $246.35M(+90.1%) |
| Jun 2021 | - | $129.61M(+63.9%) |
| Mar 2021 | - | $79.06M(+146.5%) |
| Dec 2020 | $32.07M(-19.6%) | $32.07M(-1.9%) |
| Sep 2020 | - | $32.69M(-46.0%) |
| Jun 2020 | - | $60.48M(+59.6%) |
| Mar 2020 | - | $37.90M(-5.0%) |
| Dec 2019 | $39.88M(-19.2%) | $39.88M(+6.9%) |
| Sep 2019 | - | $37.30M(+9.0%) |
| Jun 2019 | - | $34.23M(-69.5%) |
| Mar 2019 | - | $112.13M(+127.2%) |
| Dec 2018 | $49.35M(+85.6%) | $49.35M(+27.5%) |
| Sep 2018 | - | $38.71M(+34.8%) |
| Jun 2018 | - | $28.73M(-20.4%) |
| Mar 2018 | - | $36.07M(+35.7%) |
| Dec 2017 | $26.58M(+9.4%) | $26.58M(+32.3%) |
| Sep 2017 | - | $20.10M(-46.7%) |
| Jun 2017 | - | $37.67M(+75.5%) |
| Mar 2017 | - | $21.47M(-11.6%) |
| Dec 2016 | $24.29M(-45.8%) | $24.29M(+5.5%) |
| Sep 2016 | - | $23.02M(-7.1%) |
| Jun 2016 | - | $24.79M(-36.2%) |
| Mar 2016 | - | $38.86M(-13.3%) |
| Dec 2015 | $44.81M(-9.5%) | $44.81M(-56.5%) |
| Sep 2015 | - | $103.03M(+182.4%) |
| Jun 2015 | - | $36.49M(+148.0%) |
| Mar 2015 | - | $14.71M(-70.3%) |
| Dec 2014 | $49.51M | $49.51M(+151.9%) |
| Sep 2014 | - | $19.66M(+15.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $17.03M(-36.3%) |
| Mar 2014 | - | $26.75M(+15.7%) |
| Dec 2013 | $23.12M(+204.3%) | $23.12M(+89.7%) |
| Sep 2013 | - | $12.19M(-30.7%) |
| Jun 2013 | - | $17.59M(-29.7%) |
| Mar 2013 | - | $25.02M(+229.2%) |
| Dec 2012 | $7.60M(-76.2%) | $7.60M(-69.2%) |
| Sep 2012 | - | $24.65M(-28.6%) |
| Jun 2012 | - | $34.53M(+74.8%) |
| Mar 2012 | - | $19.75M(-38.2%) |
| Dec 2011 | $31.94M(+42.3%) | $31.94M(+67.5%) |
| Sep 2011 | - | $19.07M(-30.6%) |
| Jun 2011 | - | $27.48M(+31.0%) |
| Mar 2011 | - | $20.97M(-6.6%) |
| Dec 2010 | $22.45M(-38.9%) | $22.45M(-20.4%) |
| Sep 2010 | - | $28.21M(-2.9%) |
| Jun 2010 | - | $29.05M(-3.4%) |
| Mar 2010 | - | $30.08M(-18.1%) |
| Dec 2009 | $36.72M(+30.7%) | $36.72M(+48.5%) |
| Sep 2009 | - | $24.73M(+4.1%) |
| Jun 2009 | - | $23.76M(+3.7%) |
| Mar 2009 | - | $22.92M(-18.4%) |
| Dec 2008 | $28.10M(+96.6%) | $28.10M(+24.3%) |
| Sep 2008 | - | $22.62M(+52.1%) |
| Jun 2008 | - | $14.87M(-6.2%) |
| Mar 2008 | - | $15.86M(+10.9%) |
| Dec 2007 | $14.29M(+1.0%) | $14.29M(-2.4%) |
| Sep 2007 | - | $14.64M(+125.2%) |
| Jun 2007 | - | $6.50M(-49.9%) |
| Mar 2007 | - | $12.98M(-8.3%) |
| Dec 2006 | $14.15M(+62.2%) | $14.15M(-11.3%) |
| Sep 2006 | - | $15.95M(+58.1%) |
| Jun 2006 | - | $10.09M(-40.1%) |
| Mar 2006 | - | $16.84M(+93.0%) |
| Dec 2005 | $8.72M(-47.4%) | $8.72M(-54.5%) |
| Sep 2005 | - | $19.17M(+274.7%) |
| Jun 2005 | - | $5.12M(-55.1%) |
| Mar 2005 | - | $11.40M(-31.3%) |
| Dec 2004 | $16.59M(-29.3%) | $16.59M(-76.8%) |
| Sep 2004 | - | $71.51M(-3.3%) |
| Jun 2004 | - | $73.96M(-1.4%) |
| Mar 2004 | - | $75.01M(+219.6%) |
| Dec 2003 | $23.47M(+353.8%) | $23.47M |
| Dec 2002 | $5.17M | - |
FAQ
- What is Dynavax Technologies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Dynavax Technologies?
- What is Dynavax Technologies annual cash & cash equivalents year-on-year change?
- What is Dynavax Technologies quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Dynavax Technologies?
- What is Dynavax Technologies quarterly cash & cash equivalents year-on-year change?
What is Dynavax Technologies annual cash & cash equivalents?
The current annual cash & cash equivalents of DVAX is $95.88M
What is the all time high annual cash & cash equivalents for Dynavax Technologies?
Dynavax Technologies all-time high annual cash & cash equivalents is $436.19M
What is Dynavax Technologies annual cash & cash equivalents year-on-year change?
Over the past year, DVAX annual cash & cash equivalents has changed by -$54.40M (-36.20%)
What is Dynavax Technologies quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of DVAX is $51.72M
What is the all time high quarterly cash & cash equivalents for Dynavax Technologies?
Dynavax Technologies all-time high quarterly cash & cash equivalents is $436.19M
What is Dynavax Technologies quarterly cash & cash equivalents year-on-year change?
Over the past year, DVAX quarterly cash & cash equivalents has changed by -$80.31M (-60.83%)